• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?通过肝脏组织学或替代标志物评估非酒精性脂肪性肝炎的存在总是明智的吗？
Hepat Mon. 2013 Feb 20;13(2):e7560. doi: 10.5812/hepatmon.7560. Print 2013 Feb.
2
[Role of liver biopsy in the diagnosis of NASH].[肝活检在非酒精性脂肪性肝炎诊断中的作用]
Nihon Rinsho. 2006 Jun;64(6):1119-25.
3
Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.与代谢综合征相关的非酒精性脂肪性肝炎：与胰岛素抵抗及肝脏组织学的关系
J Clin Gastroenterol. 2014 Nov-Dec;48(10):883-8. doi: 10.1097/MCG.0000000000000065.
4
Nonalcoholic fatty liver disease in severely obese subjects.严重肥胖受试者的非酒精性脂肪性肝病
Am J Gastroenterol. 2007 Feb;102(2):399-408. doi: 10.1111/j.1572-0241.2006.01041.x.
5
Classification of patients with non-alcoholic fatty liver disease using rapid immunoassay of serum type IV collagen compared with liver histology and other fibrosis markers.与肝脏组织学及其他纤维化标志物相比，利用血清IV型胶原快速免疫测定法对非酒精性脂肪性肝病患者进行分类
Hepatol Res. 2017 Feb;47(2):216-225. doi: 10.1111/hepr.12710. Epub 2016 Apr 27.
6
Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients?抗氧化治疗和干扰脂质代谢的药物：对非酒精性脂肪性肝病患者有效吗？
Curr Pharm Des. 2013;19(29):5297-313.
7
Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH.他汀类药物恢复肝窦细胞表型可改善 NASH 大鼠的门脉高压和组织学。
Sci Rep. 2019 Dec 27;9(1):20183. doi: 10.1038/s41598-019-56366-2.
8
An apoptosis panel for nonalcoholic steatohepatitis diagnosis.用于非酒精性脂肪性肝炎诊断的凋亡panel。
J Hepatol. 2011 Jun;54(6):1224-9. doi: 10.1016/j.jhep.2010.08.023. Epub 2011 Feb 12.
9
Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis.生活方式的改变导致肝组织学改善与非酒精性脂肪性肝炎患者的肾功能改善独立相关。
Aliment Pharmacol Ther. 2017 Jan;45(2):332-344. doi: 10.1111/apt.13860. Epub 2016 Nov 16.
10
A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis.一项比较己酮可可碱和吡格列酮对非酒精性脂肪性肝炎患者代谢因素及肝脏组织学疗效的随机对照试验。
J Clin Exp Hepatol. 2012 Dec;2(4):333-7. doi: 10.1016/j.jceh.2012.10.010. Epub 2012 Nov 6.

引用本文的文献

1
Correlational Study of Nonalcoholic Fatty Liver Disease Diagnosed by Ultrasonography with Lipid Profile and Body Mass Index in Adult Nepalese Population.尼泊尔成年人群中超声诊断的非酒精性脂肪性肝病与血脂谱和体重指数的相关性研究。
J Med Ultrasound. 2019 Jan-Mar;27(1):19-25. doi: 10.4103/JMU.JMU_53_18. Epub 2018 Dec 5.
2
Liver biopsy versus non-invasive tests in determining liver disease status.肝活检与非侵入性检查在确定肝脏疾病状态方面的比较。
Iran J Radiol. 2015 Jan 18;12(1):e17078. doi: 10.5812/iranjradiol.17078. eCollection 2015 Jan.
3
A diagnostic model for cirrhosis in patients with non-alcoholic fatty liver disease: an artificial neural network approach.非酒精性脂肪性肝病患者肝硬化的诊断模型：一种人工神经网络方法。
Med J Islam Repub Iran. 2014 Oct 21;28:116. eCollection 2014.
4
Radiologic evaluation of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的放射学评估
World J Gastroenterol. 2014 Jun 21;20(23):7392-402. doi: 10.3748/wjg.v20.i23.7392.
5
Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies.非酒精性脂肪性肝病疑似肝活检病理评估中的观察者间和观察者内一致性
Hepat Mon. 2014 Jan 3;14(1):e15167. doi: 10.5812/hepatmon.15167. eCollection 2014 Jan.

本文引用的文献

1
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.验证 FIB4 指数在日本非酒精性脂肪性肝病人群中的应用。
BMC Gastroenterol. 2012 Jan 5;12:2. doi: 10.1186/1471-230X-12-2.
2
N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis.基于 N-糖链的生物标志物可独立于纤维化区分非酒精性脂肪性肝炎与脂肪变性。
Dig Liver Dis. 2012 Apr;44(4):315-22. doi: 10.1016/j.dld.2011.10.015. Epub 2011 Nov 25.
3
Caffeine is protective in patients with non-alcoholic fatty liver disease.咖啡因对非酒精性脂肪性肝病患者具有保护作用。
Aliment Pharmacol Ther. 2012 Jan;35(1):76-82. doi: 10.1111/j.1365-2036.2011.04916.x. Epub 2011 Nov 7.
4
Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis.荟萃分析：吡格列酮可改善非酒精性脂肪性肝炎患者的肝脏组织学和纤维化。
Aliment Pharmacol Ther. 2012 Jan;35(1):66-75. doi: 10.1111/j.1365-2036.2011.04912.x. Epub 2011 Nov 4.
5
Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.肥胖和脂肪肝是肝纤维化机制的“润滑剂”。
Dig Dis. 2011;29(4):377-83. doi: 10.1159/000329800. Epub 2011 Aug 30.
6
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.香港中文人群中质子磁共振波谱和瞬时弹性成像技术检测非酒精性脂肪性肝病及肝纤维化的流行率：一项基于人群的研究。
Gut. 2012 Mar;61(3):409-15. doi: 10.1136/gutjnl-2011-300342. Epub 2011 Aug 16.
7
Changes in diet and lifestyle and long-term weight gain in women and men.女性和男性的饮食和生活方式改变与长期体重增加。
N Engl J Med. 2011 Jun 23;364(25):2392-404. doi: 10.1056/NEJMoa1014296.
8
Close correlation of liver stiffness with collagen deposition and presence of myofibroblasts in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中肝硬度与胶原沉积和肌成纤维细胞存在密切相关。
Hepatol Res. 2011 Sep;41(9):897-903. doi: 10.1111/j.1872-034X.2011.00842.x. Epub 2011 Jun 17.
9
Validation of the non-alcoholic fatty liver disease activity score.非酒精性脂肪性肝病活动评分的验证。
Aliment Pharmacol Ther. 2011 Jul;34(2):214-8. doi: 10.1111/j.1365-2036.2011.04695.x. Epub 2011 May 18.
10
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.维生素E或二甲双胍治疗儿童和青少年非酒精性脂肪性肝病的效果：TONIC随机对照试验
JAMA. 2011 Apr 27;305(16):1659-68. doi: 10.1001/jama.2011.520.

Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?

作者信息

Tarantino Giovanni

机构信息

Department of Clinical and Experimental Medicine, School of Naples, Federico II University Medical, Naples, Italy.

出版信息

Hepat Mon. 2013 Feb 20;13(2):e7560. doi: 10.5812/hepatmon.7560. Print 2013 Feb.

DOI:10.5812/hepatmon.7560
PMID:23610586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3631528/
Abstract
摘要